{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units that are required for extraction."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Based in the initial experiments in vitro (ESA depletion experiments) as described in the example section, the mathematical model as disclosed describes the binding properties of each ESA: the association rate \"k<sub>on</sub>\" and the dissociation rate \"k<sub>0</sub>fr\" (the dissociation constant \"K<sub>D</sub>\" is defined as koff/kon).\n* The EC50 (ESA concentration required to obtain half-maximum EpoR occupancy) is calculated for each ESA and this correlates with the ESA activity in hCFU-E.\n* The amount of ESA-EpoR is, among all the other parameters, depending on the k<sub>on</sub> and the k<sub>0</sub>fr rate of the specific ESA, such as CERA.\n* In the integrative nonlinear dynamic pharmacokinetic (PK) hemoglobin (Hb) ESA-EPO-R pathway model, the integral occupancy of the ESA-EpoR is linked to Hb production, using the EC50 value of the ESA, for example the EC50 of EPOR occupancy by the ESA."}
{"final_json": [{"molecule_name": null, "protein_target_name": "EpoR", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ESA", "protein_target_name": "EpoR", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "CERA", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ESA", "protein_target_name": "EpoR", "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTable 3: Kinetic constants \nk c clear ESA clearance constant in the subcutaneous compartment k c clear sat Saturation of ESA clearance in subcutaneous compartment k c out ESA transportation constant to the blood compartment\n^clear ESA clearance constant in the blood compartment \nkon ESA-EpoR association rate / on-rate \nkoff ESA-EpoR dissociation rate / off-rate \n\u03ba<sub>\u038c</sub> ESA-EpoR dissociation constant (k<sub>0</sub>ff/k<sub>on</sub>) \nLigand- independent receptor turnover rate \nBmax Number of ESA binding sites per cell / per patient \nk<sub>e</sub> ESA-EpoR complex internalization constant \nken ESA and EpoR recycling constant \nkdi Intracellular ESA degradation constant \nkde Extracellular ESA degradation constant \nkub pro Hemoglobin production constant by the ESA-EpoR complex \nHemoglobin degradation constant (net loss of hemoglobin) \n\n\nNote that the extracted text is from Table 3, which lists kinetic constants related to ESA-EpoR interactions. However, none of the rows in the provided text snippet contain a specific numeric value with a unit for a bioactivity metric like IC50, Ki, Kd, or EC50. If you'd like, I can try to help with anything else."}
{"final_json": [{"molecule_name": "ESA", "protein_target_name": "EpoR", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ESA-EpoR complex", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units in the same sentence. The text appears to describe a pharmacokinetic model and methods for diagnosing anemic status, but it does not provide specific data that meets the required criteria."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Obtaining the half maximal effective concentrations (EC50) of a candidate ESA and a reference ESA for EPO-R activation in a first cell, \n* Preferably the calculation of the EPO-R activation in context of the above in-silico method comprises the input or the obtaining of the dissociation constant KD for at least the candidate ESA, and predicting the EPO-R activation over a period of time according to a non-linear dynamic ESA-EPO-R pathway model. \n\nNote that there are only two sentences that contain all four required components: a specific molecule name (ESA), a bioactivity metric (EC50, KD), a numeric value (not explicitly mentioned, but implied to be part of the calculation), and a unit (not explicitly mentioned, but implied to be part of the calculation). However, since the numeric value and unit are not explicitly mentioned, these sentences may not fully meet the criteria. \n\nAfter re-reading the text, I found that there are no sentences that explicitly mention a specific molecule name, a bioactivity metric, a numeric value, and a unit. The text mainly describes methods and calculations in general terms, without providing specific data. Therefore, the output is limited."}
{"final_json": [{"molecule_name": "ESA", "protein_target_name": "EPO-R", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "ESA", "protein_target_name": "EPO-R", "binding_metric": "KD", "value": null, "unit": null}]}
{"raw_mentions": "In preferred embodiments of all aspects of the invention the K<sub>D</sub> of the ESA is about 16 pM for Epoetin alfa, about 17 pM for Epoetin beta, about 789 pM for NESP and about 982 pM for CERA."}
{"final_json": [{"molecule_name": "Epoetin alfa", "protein_target_name": null, "binding_metric": "Kd", "value": "16", "unit": "pM"}, {"molecule_name": "Epoetin beta", "protein_target_name": null, "binding_metric": "Kd", "value": "17", "unit": "pM"}, {"molecule_name": "NESP", "protein_target_name": null, "binding_metric": "Kd", "value": "789", "unit": "pM"}, {"molecule_name": "CERA", "protein_target_name": null, "binding_metric": "Kd", "value": "982", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The calculated ESA-specific dissociation constant K<sub>D</sub> for the hEpoR is indicated by symbols, with values ranging from 100 pM to 400 pM.\n* Dashed lines indicated the EC50 of each ESA in the activation of the erythroprogenitors, 141 pM and 1048 pM for Epo beta and CERA respectively.\n* H838-hEpoR cells were stimulated during 10 minutes with increasing concentrations of each ESA, with EC50 values of 141 pM and 1048 pM for Epo beta and CERA respectively.\n* The ESA-EpoR mathematical model was employed to describe the depletion kinetics in all analyzed NSCLC cell lines and to determine the number of ESA binding sites / cell (B<sub>max</sub>) with a K<sub>D</sub> value of 100 pM.\n* The model could describe the depletion kinetics (model - solid line) and estimate KD and Bmax values, with a KD value of 200 pM for Epo beta."}
{"final_json": [{"molecule_name": "ESA", "protein_target_name": "hEpoR", "binding_metric": "Kd", "value": "100", "unit": "pM"}, {"molecule_name": "Epo beta", "protein_target_name": "erythroprogenitors", "binding_metric": "EC50", "value": "141", "unit": "pM"}, {"molecule_name": "CERA", "protein_target_name": "erythroprogenitors", "binding_metric": "EC50", "value": "1048", "unit": "pM"}, {"molecule_name": "Epo beta", "protein_target_name": "hEpoR", "binding_metric": "EC50", "value": "141", "unit": "pM"}, {"molecule_name": "CERA", "protein_target_name": "hEpoR", "binding_metric": "EC50", "value": "1048", "unit": "pM"}, {"molecule_name": "ESA", "protein_target_name": null, "binding_metric": "Kd", "value": "100", "unit": "pM"}, {"molecule_name": "Epo beta", "protein_target_name": null, "binding_metric": "Kd", "value": "200", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The quantitative time- resolved data in combination with our dynamic pathway model of ligand-receptor interaction enabled us to calculate that K<sub>D</sub> of Epo alpha and Epo beta, respectively, are with 16 and 17 pM very similar.\n* However, for NESP the model indicates a K<sub>D</sub> of 789 pM and for CERA a KD of 982 pM suggesting for both Epo derivatives a much elevated dissociation constant."}
{"final_json": [{"molecule_name": "Epo alpha", "protein_target_name": null, "binding_metric": "Kd", "value": "16", "unit": "pM"}, {"molecule_name": "Epo beta", "protein_target_name": null, "binding_metric": "Kd", "value": "17", "unit": "pM"}, {"molecule_name": "NESP", "protein_target_name": null, "binding_metric": "Kd", "value": "789", "unit": "pM"}, {"molecule_name": "CERA", "protein_target_name": null, "binding_metric": "Kd", "value": "982", "unit": "pM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe model predicts that a 10-fold higher concentration of CERA is required for the same activation. \nFirst these stimulations were performed for different ESA concentrations and predicted the EC50 for both Epo beta and CERA in cells with high EpoR levels (Fig. 4a)."}
{"final_json": [{"molecule_name": "CERA", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "Epo beta", "protein_target_name": "EpoR", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "CERA", "protein_target_name": "EpoR", "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nWe employed the integrative PK/PD ESA-EpoR mathematical model to calculated the EC50 (ESA concentration required to obtain half-maximum EpoR occupancy) for each ESA and determined the CERA doses that correspond to the current guidelines for NESP."}
{"final_json": [{"molecule_name": "ESA", "protein_target_name": "EpoR", "binding_metric": "EC50", "value": null, "unit": null}]}
